Thomas F. Ryan Jr., Director at REPLIGEN CORP (RGEN), sold 21,000 shares at $9.01 ($188K) on 2013-05-17, disclosed to the SEC on 2013-05-20.
Open-market sale of $188k RGEN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.95 | 4,000 | $36K | 19.0% |
| 2 | $8.95 | 10,000 | $90K | 47.5% |
| 3 | $9.00 | 1,000 | $9K | 4.8% |
| 4 | $9.01 | 6,000 | $54K | 28.7% |
| Total | $8.97 avg | 21,000 | $188K | 100% |
| Filing → |
| RGEN | SELL | 2021-08-05 | $195K | — | Filing → |
| RGEN | SELL | 2021-03-04 | $205K | — | Filing → |
| RGEN | SELL | 2020-11-13 | $351K | — | Filing → |